
8.08 Delayed Data As of Feb 03 | ![]() Today’s Change | 2.86 Today|||52-Week Range 10.82 | +32.46% Year-to-Date |
Reata Pharmaceuticals, Inc. (RETA) Soars 6.3%: Is Further Upside Left in the Stock? Feb 03 / Zacks.com - Paid Partner Content |
Previous close | 8.88 |
Today’s open | 9.24 |
Day’s range | 7.84 - 9.24 |
Volume | 14,366 |
Average volume (3 months) | 251,249 |
Market cap | $323.1M |
Earnings growth (last year) | -291.02% |
Earnings growth (this year) | +38.87% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -78.14% |
P/E ratio | NM |
Price/Sales | 2.73 |
Price/Book | 3.34 |
Today’s change | Today’s % change | |
---|---|---|
RIGLRigel Pharmaceutical... | +0.03 | +1.69% |
OTLKOutlook Therapeutics... | 0.00 | 0.00% |
---- | ||
AUTLAutolus Therapeutics... | 0.00 | 0.00% |
Next reporting date | March 15, 2023 |
EPS forecast (this quarter) | -$0.55 |
Annual revenue (last year) | $37.4M |
Annual profit (last year) | -$71.2M |
Net profit margin | -190.29% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |